Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Director Yu Soo Buys 44,895 Shares Of Aikido Pharma At An Average Price Of $6.33; Director Kyle Wool Buys 36,295 Shares Of Aikido Pharma At An Average Price Of $6.33

Author: Benzinga Newsdesk | September 14, 2022 11:32am

- SEC Form4 Filing

Posted In: AIKI